Key result
Wearable blood pressure technologies offer new opportunities for hypertension management, but require coordinated validation, data integration, and evidence-based policies to avoid increasing primary care workload and health inequalities.
Answers are grounded in this paper and cite their sources.
Wearable technologies for blood pressure measurement are emerging as potential tools for remote cardiovascular monitoring in primary care, requiring healthcare systems to prepare for their integration.
Hypertension is the most prevalent modifiable cardiovascular risk factor and leading cause of morbidity and mortality.1 The prevalence of undiagnosed hypertension in England has been rising for over a decade, so finding people with uncontrolled hypertension, and treating them to target blood pressure (BP), are key to improving outcomes. Since 2011, the National Institute for Health and Care Excellence (NICE) has recommended ambulatory BP monitoring (ABPM) for the diagnosis of hypertension.2 Primary care uptake of, and access to, ABPM have proved variable, declining since the COVID-19 pandemic, with greater use and NHS support for home BP monitoring instead.3 Novel technologies, typically integrated into watches, wristbands, or rings, offer new opportunities for self-measurement of BP and diagnosing hypertension. Many health trackers report BP trends with disclaimers against diagnostic use. In September 2025, the US Food and Drug Administration approved the Apple Watch Hypertension Notification Feature.4 Meanwhile, devices such as the Hilo wristband (Aktiia) or the CART BP ring (SkyLabs) have gained conformité européenne (CE) marks as BP measurement devices. Using photoplethysmography (PPG) to estimate BP, they either notify users of possible hypertension (Apple Watch) or report and summarise multiple 24-hour BP readings (Hilo and CART BP) via smartphone apps. > “Novel technologies, typically integrated into watches, wristbands, or rings, offer new opportunities for self-measurement of BP and diagnosing hypertension.” The NHS 10 Year Health Plan positions technology-enabled care at the centre of future healthcare delivery using real-time health data. It envisages wearable devices becoming routine tools for remote cardiovascular monitoring by 2028, and integrated within preventive pathways by 2035. To realise these ambitions, primary care must be at the forefront of interpreting and responding to wearable generated BP data. This can only happen if healthcare professionals, regulators, and health systems prepare for their integration now.
No takes yet. Share an insight, caveat, or question.
McDonagh et al. (2026) conducted an editorial in Hypertension. Wearable blood pressure measurement devices was evaluated. Wearable blood pressure technologies offer new opportunities for hypertension management, but require coordinated validation, data integration, and evidence-based policies to avoid increasing primary care workload and health inequalities.
Synapse has enriched 10 related papers. Consider them for comparative context: